Correlation Between Coloplast and Sartorius Stedim

Can any of the company-specific risk be diversified away by investing in both Coloplast and Sartorius Stedim at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Coloplast and Sartorius Stedim into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Coloplast A and Sartorius Stedim Biotech, you can compare the effects of market volatilities on Coloplast and Sartorius Stedim and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Coloplast with a short position of Sartorius Stedim. Check out your portfolio center. Please also check ongoing floating volatility patterns of Coloplast and Sartorius Stedim.

Diversification Opportunities for Coloplast and Sartorius Stedim

-0.14

Correlation Coefficient

Coloplast  Sartorius Stedim

Good diversification

The 3 months correlation between Coloplast and Sartorius is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Coloplast A and Sartorius Stedim Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sartorius Stedim Biotech and Coloplast is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Coloplast A are associated (or correlated) with Sartorius Stedim. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sartorius Stedim Biotech has no effect on the direction of Coloplast i.e., Coloplast and Sartorius Stedim go up and down completely randomly.

Pair Corralation between Coloplast and Sartorius Stedim

Assuming the 90 days horizon Coloplast A is expected to under-perform the Sartorius Stedim. But the pink sheet apears to be less risky and, when comparing its historical volatility, Coloplast A is 2.55 times less risky than Sartorius Stedim. The pink sheet trades about -0.02 of its potential returns per unit of risk. The Sartorius Stedim Biotech is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  25,690  in Sartorius Stedim Biotech on May 21, 2025 and sell it today you would lose (5,122) from holding Sartorius Stedim Biotech or give up 19.94% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	72.82%
Values	Daily Returns

Coloplast A  vs.  Sartorius Stedim Biotech

Coloplast A

Risk-Adjusted Performance

Weakest

Over the last 90 days Coloplast A has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental drivers, Coloplast is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Sartorius Stedim Biotech

Risk-Adjusted Performance

Weakest

Over the last 90 days Sartorius Stedim Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Sartorius Stedim is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Coloplast and Sartorius Stedim

The main advantage of trading using opposite Coloplast and Sartorius Stedim positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Coloplast position performs unexpectedly, Sartorius Stedim can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sartorius Stedim will offset losses from the drop in Sartorius Stedim's long position.

The idea behind Coloplast A and Sartorius Stedim Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.